title: Loss of synaptophysin-positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS.
abstract: Amyotrophic lateral sclerosis (ALS) is a common form of motor neuron disease (MND) that involves both upper and lower nervous systems. In the SOD1G93A G1H transgenic mouse, a widely used animal model of human ALS, a significant pathology is linked to the degeneration of lower motor neurons in the lumbar spinal cord and brainstem. In the current study, the number of presynaptic boutons immunoreactive for synaptophysin was estimated on retrogradely labeled soma and proximal dendrites of alpha and gamma motor neurons innervating the medial gastrocnemius muscle. No changes were detected on both soma and proximal dendrites at postnatal day 60 (P60) of alpha and gamma motor neurons. By P90 and P120, however, alpha motor neuron soma had a reduction of 14 and 33% and a dendritic reduction of 19 and 36%, respectively. By P90 and P120, gamma motor neuron soma had a reduction of 17 and 41% and a dendritic reduction of 19 and 35%, respectively. This study shows that levels of afferent innervation significantly decreased on surviving alpha and gamma motor neurons that innervate the medial gastrocnemius muscle. This finding suggests that the loss of motor neurons and the decrease of synaptophysin in the remaining motor neurons could lead to functional motor deficits, which may contribute significantly to the progression of ALS/MND.
authors.affiliation: Motor Neuron Disease Research Laboratory, Brain Injury and Repair Group, Howard Florey Institute, The University of Melbourne, Parkville, Victoria, Australia.
authors.forename: Da Wei
authors.initials: DW
authors.lastname: Zang
authors.forename: Elizabeth C
authors.initials: EC
authors.lastname: Lopes
authors.forename: Surindar S
authors.initials: SS
authors.lastname: Cheema
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D000818:Animals; D002452:Cell Count / Q000379:methods; D002470:Cell Survival / Q000235:genetics; D004195:Disease Models, Animal; D005260:Female; D007150:Immunohistochemistry / Q000379:methods; D008161:Lumbosacral Region; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009046:Motor Neurons / Q000145:classification / Q000378:metabolism* / Q000473:pathology / Q000502:physiology; D018482:Muscle, Skeletal / Q000294:innervation* / Q000378:metabolism; D017729:Presynaptic Terminals / Q000378:metabolism*; D013116:Spinal Cord / Q000473:pathology; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism; D016708:Synaptophysin / Q000172:deficiency*; D013997:Time Factors
chemical_list: D016708:Synaptophysin; C109415:SOD1 G93A protein; D013482:Superoxide Dismutase